Stepwise evolution and convergent recombination underlie the global dissemination of carbapenemase-producing Escherichia coli

Genome Med. 2020 Jan 20;12(1):10. doi: 10.1186/s13073-019-0699-6.

Abstract

Background: Carbapenem-resistant Enterobacteriaceae are considered by WHO as "critical" priority pathogens for which novel antibiotics are urgently needed. The dissemination of carbapenemase-producing Escherichia coli (CP-Ec) in the community is a major public health concern. However, the global molecular epidemiology of CP-Ec isolates remains largely unknown as well as factors contributing to the acquisition of carbapenemase genes.

Methods: We first analyzed the whole-genome sequence and the evolution of the E. coli sequence type (ST) 410 and its disseminated clade expressing the carbapenemase OXA-181. We reconstructed the phylogeny of 19 E. coli ST enriched in CP-Ec and corresponding to a total of 2026 non-redundant isolates. Using the EpiCs software, we determined the significance of the association between specific mutations and the acquisition of a carbapenemase gene and the most probable order of events. The impact of the identified mutations was assessed experimentally by genetic manipulations and phenotypic testing.

Results: In 13 of the studied STs, acquisition of carbapenemase genes occurred in multidrug-resistant lineages characterized by a combination of mutations in ftsI encoding the penicillin-binding protein 3 and in the porin genes ompC and ompF. Mutated ftsI genes and a specific ompC allele related to that from ST38 inducing reduced susceptibility to diverse β-lactams spread across the species by recombination. We showed that these mutations precede in most cases the acquisition of a carbapenemase gene. The ompC allele from ST38 might have contributed to the selection of CP-Ec disseminated lineages within this ST. On the other hand, in the pandemic ST131 lineage, CP-Ec were not associated with mutations in ompC or ftsI and show no signs of dissemination.

Conclusions: Lineages of CP-Ec have started to disseminate globally. However, their selection is a multistep process involving mutations, recombination, acquisition of antibiotic resistance genes, and selection by β-lactams from diverse families. This process did not yet occur in the high-risk lineage ST131.

Keywords: Bacterial evolution; Carbapenems; Lateral gene transfers; Multidrug resistance; Penicillin-binding proteins; Porin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacterial Proteins / genetics*
  • Bacterial Proteins / metabolism
  • Enteropathogenic Escherichia coli / classification
  • Enteropathogenic Escherichia coli / drug effects
  • Enteropathogenic Escherichia coli / genetics*
  • Escherichia coli Proteins / genetics
  • Evolution, Molecular*
  • Gene Transfer, Horizontal*
  • Mutation
  • Penicillin-Binding Proteins / genetics
  • Peptidoglycan Glycosyltransferase / genetics
  • Phylogeny
  • Porins / genetics
  • beta-Lactam Resistance*
  • beta-Lactamases / genetics*
  • beta-Lactamases / metabolism

Substances

  • Bacterial Proteins
  • Escherichia coli Proteins
  • FtsI protein, E coli
  • OmpC protein
  • OmpF protein
  • Penicillin-Binding Proteins
  • Porins
  • Peptidoglycan Glycosyltransferase
  • beta-Lactamases
  • carbapenemase